Stephanie A S Staras1, Susan T Vadaparampil2, Melvin D Livingston3, Lindsay A Thompson4, Ashley H Sanders3, Elizabeth A Shenkman4. 1. Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, Florida; Institute for Child Health Policy, University of Florida, Gainesville, Florida. Electronic address: sstaras@ufl.edu. 2. Health Outcomes and Behavior Program, H. Lee Moffitt Cancer Center, Tampa, Florida. 3. Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, Florida; Institute for Child Health Policy, University of Florida, Gainesville, Florida. 4. Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, Florida; Institute for Child Health Policy, University of Florida, Gainesville, Florida; Department of Pediatrics, University of Florida, Gainesville, Florida.
Abstract
PURPOSE: We evaluated the feasibility of a multilevel intervention to increase the human papillomavirus (HPV) vaccine initiation among adolescents. METHODS: We used a four-arm factorial, quasi-experimental trial to assess feasibility and short-term, preliminary effectiveness of a health system-level, gender-specific postcard campaign and an in-clinic health information technology (HIT) system. Between August and November 2013, we tested the intervention among 11- to 17-year-olds without prior HPV vaccine claims in the Florida Medicaid orChildren's Health Insurance Program encounters (2,773 girls and 3,350 boys) who attended or were assigned to primary care clinics in North Central Florida. RESULTS: At least one postcard was deliverable to 95% of the parents. Most parents (91% boys' and 80% girls') who participated in the process evaluation survey (n = 162) reported seeking additional information about the vaccine after receiving the postcard. Only 8% (57 of 1,062) of the adolescents assigned to a HIT provider with an office visit during the study used the HIT system. When compared with arms not containing that component, HPV vaccine initiation increased with the postcard campaign (girls, odds ratio [OR] = 1.6; 95% confidence interval [CI] = 1.1-2.3 and boys, not significant), the HIT system (girls, OR = 1.5; 95% CI = 1.0-2.3 and boys, OR = 1.4; 95% CI = 1.0-2.0), and the combined HIT and postcard intervention (girls, OR = 2.4; 95% CI = 1.4-4.3 and boys, OR = 1.6; 95% CI = 1.0-2.5). CONCLUSIONS: A system-level postcard campaign was feasible. Despite low recruitment to the in-clinic HIT system, the intervention demonstrated short-term, preliminary effectiveness similar to prior HPV vaccine interventions.
RCT Entities:
PURPOSE: We evaluated the feasibility of a multilevel intervention to increase the human papillomavirus (HPV) vaccine initiation among adolescents. METHODS: We used a four-arm factorial, quasi-experimental trial to assess feasibility and short-term, preliminary effectiveness of a health system-level, gender-specific postcard campaign and an in-clinic health information technology (HIT) system. Between August and November 2013, we tested the intervention among 11- to 17-year-olds without prior HPV vaccine claims in the Florida Medicaid or Children's Health Insurance Program encounters (2,773 girls and 3,350 boys) who attended or were assigned to primary care clinics in North Central Florida. RESULTS: At least one postcard was deliverable to 95% of the parents. Most parents (91% boys' and 80% girls') who participated in the process evaluation survey (n = 162) reported seeking additional information about the vaccine after receiving the postcard. Only 8% (57 of 1,062) of the adolescents assigned to a HIT provider with an office visit during the study used the HIT system. When compared with arms not containing that component, HPV vaccine initiation increased with the postcard campaign (girls, odds ratio [OR] = 1.6; 95% confidence interval [CI] = 1.1-2.3 and boys, not significant), the HIT system (girls, OR = 1.5; 95% CI = 1.0-2.3 and boys, OR = 1.4; 95% CI = 1.0-2.0), and the combined HIT and postcard intervention (girls, OR = 2.4; 95% CI = 1.4-4.3 and boys, OR = 1.6; 95% CI = 1.0-2.5). CONCLUSIONS: A system-level postcard campaign was feasible. Despite low recruitment to the in-clinic HIT system, the intervention demonstrated short-term, preliminary effectiveness similar to prior HPV vaccine interventions.
Authors: Cynthia M Rand; Sharon G Humiston; Stanley J Schaffer; Christina S Albertin; Laura P Shone; Aaron K Blumkin; Shannon Stokley; Peter G Szilagyi Journal: Vaccine Date: 2011-08-12 Impact factor: 3.641
Authors: Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Alison M McDonald; Rosemary C Knight; Marion K Campbell; Vikki A Entwistle; Adrian M Grant; Jonathan A Cook; Diana R Elbourne; David Francis; Jo Garcia; Ian Roberts; Claire Snowdon Journal: Trials Date: 2006-04-07 Impact factor: 2.279
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Peter Szilagyi; Christina Albertin; Dennis Gurfinkel; Brenda Beaty; Xinkai Zhou; Sitaram Vangala; John Rice; Jonathan D Campbell; Melanie D Whittington; Rebecca Valderrama; Abigail Breck; Heather Roth; Megan Meldrum; Chi-Hong Tseng; Cynthia Rand; Sharon G Humiston; Stanley Schaffer; Allison Kempe Journal: Pediatrics Date: 2020-04-06 Impact factor: 7.124
Authors: Jennifer C Spencer; Noel T Brewer; Justin G Trogdon; Morris Weinberger; Tamera Coyne-Beasley; Stephanie B Wheeler Journal: Pediatrics Date: 2020-11-16 Impact factor: 7.124
Authors: Jennifer C Spencer; Noel T Brewer; Tamera Coyne-Beasley; Justin G Trogdon; Morris Weinberger; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-09-09 Impact factor: 4.254
Authors: Leila H Abdullahi; Benjamin M Kagina; Valantine Ngum Ndze; Gregory D Hussey; Charles S Wiysonge Journal: Cochrane Database Syst Rev Date: 2020-01-17
Authors: Julie C Jacobson Vann; Robert M Jacobson; Tamera Coyne-Beasley; Josephine K Asafu-Adjei; Peter G Szilagyi Journal: Cochrane Database Syst Rev Date: 2018-01-18
Authors: Anna Acampora; Adriano Grossi; Andrea Barbara; Vittoria Colamesta; Francesco Andrea Causio; Giovanna Elisa Calabrò; Stefania Boccia; Chiara de Waure Journal: Int J Environ Res Public Health Date: 2020-10-30 Impact factor: 3.390
Authors: Stephanie A S Staras; Susan T Vadaparampil; Lindsay A Thompson; Courtney Scherr; Matthew J Gurka; Stephanie L Filipp; Elizabeth A Shenkman Journal: Prev Med Rep Date: 2020-08-26